Levetiracetam Tablet, Film Coated
Product Images NDC 68180-115

18 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 68180-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (24fe2e98 0b9f 4eea A745 E26002329cec 01)

Figure 1 (24fe2e98 0b9f 4eea A745 E26002329cec 01)
A formula calculation panel showing how to determine total daily dose for Levetiracetam based on daily dose per kg per day multiplied by patient weight in kilograms, then divided by 100 mg/mL concentration.*
FDA Label Image

Figure 2 (24fe2e98 0b9f 4eea A745 E26002329cec 02)

Figure 2 (24fe2e98 0b9f 4eea A745 E26002329cec 02)
A text panel displaying formulas used to calculate creatinine clearance (CLcr), including age, weight, serum creatinine, and adjustments for body surface area (BSA). It specifies multiplication by 0.85 for female patients and shows the formula for adjusting CLcr in mL/min per 1.73 square meters of BSA.*
FDA Label Image

Structure (24fe2e98 0b9f 4eea A745 E26002329cec 03)

Structure (24fe2e98 0b9f 4eea A745 E26002329cec 03)
Chemical structure of the active ingredient Levetiracetam, depicting the molecular arrangement of atoms including a pyrrolidone ring and side chains with amide and ethyl groups.*
FDA Label Image

Figure 4 (24fe2e98 0b9f 4eea A745 E26002329cec 04)

Figure 4 (24fe2e98 0b9f 4eea A745 E26002329cec 04)
A bar chart comparing the percentage of patients across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The chart shows approximately 7.4% for the Placebo group, 37.1% for Levetiracetam 1000 mg/day, and 39.6% for Levetiracetam 3000 mg/day, with the patient counts indicated below each group.*
FDA Label Image

Figure 5 (24fe2e98 0b9f 4eea A745 E26002329cec 05)

Figure 5 (24fe2e98 0b9f 4eea A745 E26002329cec 05)
A bar chart showing the percentage of patients for three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day, with values of approximately 6.3%, 20.8%, and 35.2% respectively. The chart compares patient response rates across these treatment groups.*
FDA Label Image

Figure 6 (24fe2e98 0b9f 4eea A745 E26002329cec 06)

Figure 6 (24fe2e98 0b9f 4eea A745 E26002329cec 06)
A bar graph comparing the percentage of patients responding to Placebo (14.4%, N=104) versus Levetiracetam 3000 mg/day (39.4%, N=180). The y-axis represents the percentage of patients, ranging from 0% to 45%, with Levetiracetam showing a notably higher response rate.*
FDA Label Image

Figure 7 (24fe2e98 0b9f 4eea A745 E26002329cec 07)

Figure 7 (24fe2e98 0b9f 4eea A745 E26002329cec 07)
A bar chart comparing the percentage of patients in two groups: Placebo (N=97) and Levetiracetam (N=101). The chart shows about 19.6% of patients in the placebo group and 44.6% in the Levetiracetam group, with percentage of patients on the vertical axis.*
FDA Label Image

Figure 8 (24fe2e98 0b9f 4eea A745 E26002329cec 08)

Figure 8 (24fe2e98 0b9f 4eea A745 E26002329cec 08)
Bar chart comparing the percentage of patients between two groups: Placebo (N=51) with 19.6%, and Levetiracetam (N=58) with 43.1%. The y-axis represents the percentage of patients, ranging from 0% to 45%. This figure likely shows a comparative outcome between placebo and Levetiracetam treatment groups.*
FDA Label Image

Figure 9 (24fe2e98 0b9f 4eea A745 E26002329cec 09)

Figure 9 (24fe2e98 0b9f 4eea A745 E26002329cec 09)
A bar graph comparing the percentage of patients between Placebo (N=84) and Levetiracetam (N=79). The Placebo group shows 45.2% of patients, while the Levetiracetam group shows 72.2%. The y-axis represents the percentage of patients from 0% to 100%.*
FDA Label Image

Image (D1c36ef8 B1ae 459b B232 Dec8100baf09 615 1)

FDA Label Image

Image (D1c36ef8 B1ae 459b B232 Dec8100baf09 638 1)

Image (D1c36ef8 B1ae 459b B232 Dec8100baf09 638 1)
Chemical structure diagram of Levetiracetam, showing the molecular framework with labeled atoms and bonds consistent with the active ingredient Levetiracetam.*
FDA Label Image

Figure 10 (24fe2e98 0b9f 4eea A745 E26002329cec 10)

Figure 10 (24fe2e98 0b9f 4eea A745 E26002329cec 10)
Levetiracetam Tablets USP 250 mg film-coated tablet label by Lupin Pharmaceuticals, Inc. The label includes the NDC 68180-112-02 and indicates a quantity of 500 tablets. It provides storage instructions, pharmacist guidance, and directs users to a Medication Guide online. Manufactured by Lupin Limited in India, with packaging details and a barcode present.*
FDA Label Image

250mg-500s (24fe2e98 0b9f 4eea A745 E26002329cec 11)

250mg-500s (24fe2e98 0b9f 4eea A745 E26002329cec 11)
Label for Levetiracetam Tablets USP 250 mg by Lupin Pharmaceuticals, Inc. The label indicates 500 tablets per bottle and includes storage and dispensing instructions, manufacturer details in India, a barcode, and a QR code for prescribing information.*
FDA Label Image

Figure 12 (24fe2e98 0b9f 4eea A745 E26002329cec 12)

Figure 12 (24fe2e98 0b9f 4eea A745 E26002329cec 12)
Label for Levetiracetam Tablets USP 500 mg by Lupin Pharmaceuticals, Inc. The label specifies 500 tablets per container, with NDC 68180-113-02. It notes pharmacist instructions to dispense the Medication Guide, storage conditions at 25°C, manufacturer details in India, and includes a barcode and QR code for the Medication Guide.*
FDA Label Image

500mg-500s (24fe2e98 0b9f 4eea A745 E26002329cec 13)

500mg-500s (24fe2e98 0b9f 4eea A745 E26002329cec 13)
Levetiracetam Tablets USP 500 mg label from Lupin Pharmaceuticals, Inc. The label indicates the product contains 500 film-coated tablets, each with 500 mg of levetiracetam. It includes storage instructions, pharmacist dispensing guidance, manufacturer information, a barcode, and a QR code linking to prescribing information and medication guide.*
FDA Label Image

14 (24fe2e98 0b9f 4eea A745 E26002329cec 14)

14 (24fe2e98 0b9f 4eea A745 E26002329cec 14)
Levetiracetam Tablets USP 750 mg film-coated tablets label from Lupin Pharmaceuticals, Inc. The label states 500 tablets per container with storage instructions and dispensing guidance for pharmacists. It includes the NDC 68180-114-02, manufacturer details including Lupin Limited in India, and a QR code for the medication guide.*
FDA Label Image

750mg-500s (24fe2e98 0b9f 4eea A745 E26002329cec 15)

750mg-500s (24fe2e98 0b9f 4eea A745 E26002329cec 15)
Packaging label for Levetiracetam Tablets USP 750 mg by Lupin Pharmaceuticals, Inc. The label indicates the product contains 500 tablets and is prescription only. It includes NDC 68180-114-02, storage instructions, dispensing guidance, and manufacturing details for Lupin Limited, India.*
FDA Label Image

16 (24fe2e98 0b9f 4eea A745 E26002329cec 16)

16 (24fe2e98 0b9f 4eea A745 E26002329cec 16)
Levetiracetam Tablets USP 1000 mg film-coated tablets label from Lupin Pharmaceuticals, Inc. The label indicates a package of 60 tablets. It includes dosing, storage instructions, pharmacy dispensing advice, manufacturer details (Lupin Limited, India), and a QR code for the Medication Guide. The label measures 99 mm by 45 mm.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.